Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.

Dose injected directly into vein or running intravenous fluids. ‡ Intermittent intravenous infusion ... Intravenous is preferred over topical, subcutaneous or mechanical bowel preparation ...

2005;62(21):2260-2264. Verify that the patient is receiving some source of exogenous glucose before initiating infusion (e.g., total parenteral nutrition [TPN], i.v. fluids containing dextrose ...

The reduced performance of the 3-mm tubing makes administration systems incorporating even short lengths of this diameter of tubing unsuitable in emergency situations and locations where rapid ...

In the placebo arm patients received methotrexate placebo and tocilizumab placebo for 8 weeks (two infusions); from week 8 placebo infusion was replaced by tocilizumab 8 mg/kg infusion ... 1.06 vs ...